Previous 10 | Next 10 |
ABNB, ACHC, ADC, AHT, AIG, AIZ, AKAM, ALR, AMCR, AMD, ANDE, APPH, AQST, ATEN, AYX, BFAM, BGFV, BLKB, BNFT, BNL, BTG, BXC, CGBD, CHCT, CNDT, CNR, COKE, CRK, CRUS, CTSO, CWH, CZR, DENN, DHC, DMTK, EGY, EHTH, EIX, ENLC, ENVA, EQX, EXR, FLGT, FPI, FRSH, GLAD, GLRE, GNW, GPOR, GRBK, HASI, HLF, HRZ...
DermTech , Inc. (NASDAQ: DMTK) (“DermTech” or the “Company”), a leader in precision dermatology enabled by a non-invasive skin genomics platform, announced today the publication of “ Noninvasive Genomic Characterization of Patients with Nonsclero...
DermTech (NASDAQ:DMTK) shares are on the rise in the post-market Tuesday after the molecular diagnostic company announced it was broadening the access to its telehealth application, DermTech Connect, from eight states to 44 states. Accordingly, the app will be accessible in all states except ...
DermTech , Inc. (NASDAQ: DMTK) (“DermTech” or the “Company”), a leader in precision dermatology enabled by a non-invasive skin genomics platform, announced today the expansion of access to its telehealth application, DermTech Connect, from eight states to...
DermTech , Inc. (NASDAQ: DMTK) (“DermTech” or the “Company”), a leader in precision dermatology enabled by a non-invasive skin genomics platform, will host a conference call and webcast on Tuesday, May 3, 2022 at 5:00 p.m. Eastern Time (ET) to discuss...
DMTK’s SmartSticker solution is proprietary and has been shown to be more effective and accurate than traditional biopsy-based diagnostic approaches, but the company must further commercialize this offering. DMTK has made significant sales, marketing and infrastructure investme...
DermTech, Inc. (NASDAQ: DMTK) (“DermTech”), a leader in precision dermatology enabled by a non-invasive skin genomics platform, today announced the grant to one new employee of restricted stock units representing the contingent right to receive up to an aggregate of 51,934...
DermTech, Inc. (NASDAQ: DMTK) (“DermTech” or the “Company”), a leader in precision dermatology enabled by a non-invasive skin genomics platform, announced today that SKIN: The Journal of Cutaneous Medicine has published its original research study, wi...
DermTech, Inc. (DMTK) Q4 2021 Earnings Conference Call March 01, 2022, 04:30 PM ET Company Participants Caroline Corner - Investor Relations John Dobak - President and Chief Executive Officer Kevin Sun - Chief Financial Officer Conference Call Participants Max Masucci - Cowen & Company Ke...
DermTech press release (NASDAQ:DMTK): Q4 GAAP EPS of -$0.88 misses by $0.14. Revenue of $3.17M (+51.0% Y/Y) misses by $0.16M. Shares -4.3%. For further details see: DermTech GAAP EPS of -$0.88 misses by $0.14, revenue of $3.17M misses by $0.16M